The Future of NSCLC: Molecular Profiles Guiding Treatment Decisions
June 14th 2011The authors of "ALK-Targeted Therapy for Lung Cancer: Ready for Prime Time," in this issue of ONCOLOGY, address the newest developments in the field of targeted therapies for advanced non–small-cell lung cancer (NSCLC).